Five-year evolution of drug prescribing in a university adult intensive care unit

Por Voirol, P, Eggimann, P, Carron, C, Pannatier, A, Chiolero, R, Wasserfallen, JB
Publicado em 2010

Risk factors for hypertriglyceridemia in the intensive care unit: an exploratory study

Por Devaud, JC, Voirol, P, Marques-Vidal, P, Tappy, L, Rodondi, N, Chiolero, R, Berger, MM, Pannatier, A
Publicado em 2010

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage

Por Schneider, AS, Voirol, P, Perez, M, Schoettker, P, Wasserfallen, JB, Angelillo-Scherrer, A, Chiolero, R, Cotting, J, Eggimann, P
Publicado em 2009

Impact of Real-Time Therapeutic Drug Monitoring on the Prescription of Antibiotics in Burn Patients Requiring Admission to the Intensive Care Unit

Por Fournier, A., Eggimann, P., Pantet, O., Pagani, J. L., Dupuis-Lozeron, E., Pannatier, A., Sadeghipour, F., Voirol, P., Que, Y.-A.
Publicado no Antimicrob Agents Chemother (2018)

Reply to Sorooshian and Snow, “Is Alternate-Day Therapeutic Drug Monitoring in the Intensive Care Unit Not Intensive Enough?”

Por Fournier, A., Eggimann, P., Pantet, O., Pagani, J. L., Dupuis-Lozeron, E., Pannatier, A., Sadeghipour, F., Voirol, P., Que, Y.-A.
Publicado no Antimicrob Agents Chemother (2018)

Safety of activated recombinant factor VII in patients with circulatory assist devices

Por Schneider, AS, Tozzi, P, Voirol, P, Schoettker, P, Perez, MH, Angelillo-Scherrer, A, Wasserfallen, J, Chiolero, R, Cotting, J, Von Segesser, L, Eggimann, P
Publicado em 2009

Antibiotics’ consumption to early detect epidemics of P. aeruginosa in a burn center: a paradigm shift in the epidemiological surveillance of nosocomial infections

Por Fournier, A, Eggimann, P, Pantet, O, Krähenbühl, M, Bonnemain, C-L, Fournier, C, Pagani, J-L, Revelly, J-P, Dupuis-Lozeron, E, Sadeghipour, F, Pannatier, A, Voirol, P, Que, Y-A
Publicado no Antimicrob Resist Infect Control (2015)